Skip to main content

Propel Bio Management, LLC

SEC CIK
0001969764
Latest filing
Aug 13, 2026

OCUL holding history

Ocular Therapeutix, Inc in every 13F filed by Propel Bio Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OCUL overviewAll 13F holders of OCULFull Q2 2026 holdings

Shares (Q2 2026)
357,966
Value
$3.52M
% of portfolio
1.8%
Quarters held
2
Since Q1 2026
Holdings of OCUL by Propel Bio Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026357,966$3.52M1.8%−24,409−6.4%ReducedHolders
Q1 2026382,375$3.23M2.0%+382,375NewHolders